Liraglutide is a synthetic GLP-1 receptor agonist used to treat type 2 diabetes, obesity, and in some cases, to reduce cardiovascular risk. It works by mimicking the hormone GLP-1 (glucagon-like peptide-1), which helps regulate blood sugar, slows gastric emptying, and reduces appetite.